Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UK incentives will attract more like us, says Eisai executive

This article was originally published in Scrip

Executive Summary

Measures announced in the UK Budget this week "have vindicated our decision to locate a hub in the UK" and will lead other pharmaceutical companies "to redirect investments to the UK now", Gary Hendler, president and CEO of Japanese pharma group Eisai's EMEA operations, told Scrip.

Advertisement

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register